Basel Medical Group Ltd Ordinary Shares (BMGL) — Cash Flow-to-Debt Ratio
Basel Medical Group Ltd Ordinary Shares (BMGL) has a Cash Flow-to-Debt Ratio of -0.36x as of June 2025, meaning its operating cash flow of $-4.34 Million could theoretically repay 0% of its total liabilities ($11.99 Million) in one year. See Basel Medical Group Ltd Ordinary Shares financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Basel Medical Group Ltd Ordinary Shares Cash Flow-to-Debt Ratio (2022–2025)
Historical debt coverage capacity for Basel Medical Group Ltd Ordinary Shares across 4 annual periods. For the full cash flow conversion analysis, see Basel Medical Group Ltd Ordinary Shares operating cash flow efficiency.
Annual Cash Flow-to-Debt Ratio for Basel Medical Group Ltd Ordinary Shares (2022–2025)
Year-by-year debt coverage analysis for Basel Medical Group Ltd Ordinary Shares. Check cash flow quality index of Basel Medical Group Ltd Ordinary Shares to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.36x | $-4.34 Million | $11.99 Million | ▼ -226.3% |
| 2024 | 0.29x | $2.51 Million | $8.75 Million | ▲ +9.1% |
| 2023 | 0.26x | $2.60 Million | $9.89 Million | ▲ +23.7% |
| 2022 | 0.21x | $2.79 Million | $13.14 Million | — |